Does AZD-1222 Cause Off label use? 463 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 463 reports of Off label use have been filed in association with AZD-1222. This represents 19.8% of all adverse event reports for AZD-1222.
463
Reports of Off label use with AZD-1222
19.8%
of all AZD-1222 reports
4
Deaths
113
Hospitalizations
How Dangerous Is Off label use From AZD-1222?
Of the 463 reports, 4 (0.9%) resulted in death, 113 (24.4%) required hospitalization, and 61 (13.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZD-1222. However, 463 reports have been filed with the FAERS database.
What Other Side Effects Does AZD-1222 Cause?
Headache (838)
Fatigue (784)
Pyrexia (735)
Pain (579)
Covid-19 (515)
Arthralgia (508)
Nausea (494)
Palpitations (485)
Dyspnoea (472)
Abdominal discomfort (467)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which AZD-1222 Alternatives Have Lower Off label use Risk?
AZD-1222 vs AZELAIC ACID
AZD-1222 vs AZELASTINE
AZD-1222 vs AZELASTINE\FLUTICASONE
AZD-1222 vs AZELNIDIPINE
AZD-1222 vs AZILECT